SCHEMBL7082674

SCHEMBL7082674

Cc1ccc(-c2cc(O)cc(O)c2)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.52
ABCB1 P08183 3/20 0.52
BCR P11274 3/20 0.52
GAA P10253 1/20 0.48
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
MAPK1 P28482 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
CASP3 P42574 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
APP P05067 1/20 0.44
ACHE P22303 1/20 0.43
TRPA1 O75762 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47861 0.88 TSHR (0.56) HSD17B1HSD17B2MAPK1TP53TSHR
SCHEMBL13695146 0.84 TSHR (0.48) HSD17B1HSD17B2MAPK1TSHRCASP1
SCHEMBL7084047 0.82 HSD17B1 (0.68) ABL1ABCB1BCRGAAHSD17B1
SCHEMBL12387990 0.81 APP (0.70) TSHRCASP1APPACHETRPA1
SCHEMBL14295102 0.81 MCL1 (0.57) HSD17B1HSD17B2MAPK1TSHRCASP1
SCHEMBL1007614 0.79 MCL1 (0.52) HSD17B1HSD17B2MAPK1TP53TSHR
SCHEMBL31344493 0.79 HSD17B1 (0.59) HSD17B1HSD17B2MAPK1TP53TSHR
SCHEMBL31212445 0.79 HSD17B1 (0.59) HSD17B1HSD17B2MAPK1TP53TSHR
SCHEMBL29319710 0.78 ABL1 (0.48) ABL1ABCB1BCRGAAHSD17B1
SCHEMBL25420702 0.78 APP (0.74) ABL1ABCB1BCRHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030139479-A1 Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same WARNER-LAMBERT COMPANY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139479-A1 Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same AS3MT, PTPN1, NONO ABL1 157/4885ABCB1 105/4885BCR 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.